GSTP1 and neuropathy: In a group of 64 evaluable patients receiving a minimal cumulative dose of 500 mg m−2 of OX, the cumulative neuropathy grade 3 was significantly more frequent in patients who were homozygous for the GSTP1 105Ile allele than in patients homozygous or heterozygous for the 105Val allele.